74 results
8-K
EX-1.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
or in the aggregate, has had or would have (nor does the Company nor any of its subsidiaries have any notice or knowledge of any tax deficiency or tax audit
8-K
CNTA
Centessa Pharmaceuticals plc
25 Jun 24
Submission of Matters to a Vote of Security Holders
4:14pm
, for the financial year ending December 31, 2024.
To authorize the Audit Committee to determine the Company’s auditors’ remuneration for the financial
DEFA14A
99kx7t2v
20 May 24
Additional proxy soliciting materials
8:48pm
PRE 14A
668xiv
26 Apr 24
Preliminary proxy
4:36pm
8-K
EX-1.1
dxoc1 3za
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am